Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: A multifactorial disease

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 4, 2013, Pages

  Gómez Traseira, Carmen ^a,b   López Lera, Alberto ^a,b,c   Drouet, Christian ^d   López Trascasa, Margarita ^a,b,c   Pérez Fernández, Elia ^a,b   Favier, Bertrand ^d   Prior, Nieves ^a,b   Caballero, Teresa ^a,b,c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; COMPLEMENT COMPONENT C1S INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENZYME PRECURSOR; METALLOPROTEINASE;

ANGIONEUROTIC EDEMA; CATABOLISM; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; LETTER; LIGAND BINDING; MALE; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 84884900459     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.04.032     Document Type: Article

References (11)

1. B.L. Zuraw, K. Bork, K.E. Binkley, A. Banerji, S.C. Christiansen, and A. Castaldo Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel Allergy Asthma Proc 33 2012 145 156
2. T. Caballero, M.L. Baeza, R. Cabañas, A. Campos, S. Cimbollek, and C. Gómez-Traseira Spanish consensus on the diagnosis, management and treatment of angio-oedema mediated by bradykinin, part I: classification, epidemiology, pathophysiology, genetics, clinical symptoms and diagnosis J Investig Allergol Clin Immunol 21 2011 333 347
3. K. Bork, K. Wulff, P. Meinke, N. Wagner, J. Hardt, and G. Witzke A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor Clin Immunol 141 2011 31 35
4. S. Cichon, L. Martin, H. Christian, F. Müller, K. Van Driessche, and A. Karpushova Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III Am J Hum Genet 79 2006 1098 1104
5. A.P. Kaplan, and B. Ghebrehiwet The plasma bradykinin-forming pathways and its interrelationships with complement Mol Immunol 47 2010 2161 2169
6. F. Defendi, D. Charignon, F. Csopaki, D. Ponard, and C. Drouet Actualités biologiques sur les angiodémes à kinines Rev fr Laboratoires 42 2012 55 68
7. C. Marcos, A. López Lera, S. Varela, T. Liñares, M.G. Alvarez-Eire, and M. López-Trascasa Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families Ann Allergy Asthma Immunol 109 2012 195 200
8. L. Martin, N. Raison-Peyron, M.M. Nöthen, S. Cichon, and C. Drouet Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene J Allergy Clin Immunol 120 2007 975 977
9. C. Kluft Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein J Lab Clin Med 91 1978 83 95
10. C. Drouet, A. Désormeaux, J. Robillard, D. Ponard, L. Bouillet, and L. Martin Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P J Allergy Clin Immunol 121 2008 429 433
11. Q.L. Duan, K. Binkley, and G.A. Rouleau Genetic analysis of factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema J Allergy Clin Immunol 123 2009 906 910